Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.

Oncotarget - 24 Jan 2017

Geng Xin, Pu Weilin, Tan Yulong, Lu Zhouyi, Wang An, Tan Lixing, Chen Sidi, Guo Shicheng, Wang Jiucun, Chen Xiaofeng

Abstract excerpt

Aberrant methylation of CpG islands acquired in promoter regions plays an important role in carcinogenesis. Accumulated evidence demonstrates FHIT gene promoter hyper-methylation is involved in non-small cell lung cancer (NSCLC). To test the diagnostic ability of FHIT methylation status on NSCLC, thirteen studies, including 2,119 samples were included in our meta-analysis. Simultaneously, four independent DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acid Anhydride Hydrolases
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CpG Islands

Share to Databases, Genetic

Share to DNA Methylation

Share to Neoplasm Proteins

Share to Predictive Value of Tests

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 28036263
DOI: 10.18632/oncotarget.14256
PMCID: PMC5351674

Genes

FHIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.PMID 28036263Read ↗

Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lungSemantic proximity Read ↗

Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.Semantic proximity Read ↗

DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateSemantic proximity Read ↗

A Panel of DNA Methylation Biomarkers for Detection and Improving Diagnostic Efficiency of Lung CancerSemantic proximity Read ↗

Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.Semantic proximity Read ↗

SCT promoter methylation is a highly discriminative biomarker for lung and many other cancersSemantic proximity Read ↗

The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC)Semantic proximity Read ↗

Detection of the DNA methylation of seven genes contribute to the early diagnosis of lung cancerSemantic proximity Read ↗

Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.Semantic proximity Read ↗

Genome-wide analysis of DNA methylation in bronchial washingsSemantic proximity Read ↗

P16INK4a gene promoter methylation as a biomarker for the diagnosis of non‐small cell lung cancer: An updated meta‐analysisSemantic proximity Read ↗

High level of FHL2 exacerbates the outcome of non-small cell lung cancer (NSCLC) patients and the malignant phenotype in NSCLC cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.